Disposition of 1628513 shares by Klein Lawrence Otto of ORKA at 7.8 subject to Rule 16b-3
| ORKA Stock | 10.53 0.11 1.03% |
About 63% of Oruka Therapeutics,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Oruka Therapeutics, suggests that many traders are alarmed. The current market sentiment, together with Oruka Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Oruka Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Oruka |
Filed transaction by ORKA Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at news.google.com
 |
Oruka Therapeutics, Fundamental Analysis
We analyze Oruka Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oruka Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oruka Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Oruka Therapeutics, is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Oruka Therapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oruka Therapeutics, stock to make a market-neutral strategy. Peer analysis of Oruka Therapeutics, could also be used in its relative valuation, which is a method of valuing Oruka Therapeutics, by comparing valuation metrics with similar companies.
Peers
Oruka Therapeutics, Related Equities
| ENLT | Enlight Renewable | 3.32 | ||||
| PKE | Park Electrochemical | 0.95 | ||||
| ECL | Ecolab | 0.29 | ||||
| CNP | CenterPoint Energy | 0.53 | ||||
| APD | Air Products | 1.11 | ||||
| ALTO | Alto Ingredients | 1.71 | ||||
| NL | NL Industries | 1.82 | ||||
| ARIS | Aris Water | 2.60 |
Complementary Tools for Oruka Stock analysis
When running Oruka Therapeutics,'s price analysis, check to measure Oruka Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oruka Therapeutics, is operating at the current time. Most of Oruka Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Oruka Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oruka Therapeutics,'s price. Additionally, you may evaluate how the addition of Oruka Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |